• 1. Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China;
  • 2. Laboratory of Cardiovascular Diseases, Research Center of Regeneration Medicine, West China Hospital, Sichuan University, Chengdu 610041, China;
  • 3. General Practice Branch, West China Hospital, Sichuan University, Chengdu 610041, China;
LUOFengming, Email: Luofengming@hotmail.com
Export PDF Favorites Scan Get Citation

This study aims to construct the plasmid of human Runx1 and observe its possible effects on Runx1 gene expression in human pulmonary adenocarcinoma cells (A549). The shRNA sequence targeting human Runx1 was designed and synthesized, then inserted into pSuper plasmid by DNA recombination technology. The recombinant plasmid was confirmed by bacterial colonies PCR, enzyme digestion analysis and DNA sequencing. A549 cells were transfected by Runx1 shRNA plasmid. The inhibition efficiency of pSuper-Runx1-shRNA plasmid on Runx1 at mRNA level and protein level were measured with real-time PCR and Western blot. The results of real-time PCR and Western blot indicated that the mRNA and protein levels of Runx1 in A549 cells were inhibited by the pSuper-Runx1-shRNA expression plasmid, and the inhibition rate were 33% and 50%, respectively.

Citation: CHENYifan, TANGXiaoju, LUOFengming. Construction and Expression of Runx1-shRNA Expressiong Plasmid. Journal of Biomedical Engineering, 2014, 31(4): 837-841. doi: 10.7507/1001-5515.20140157 Copy

  • Previous Article

    Antioxidant Function of Solanesol and Its Inhibitory Effect on Tyrosinase
  • Next Article

    Primary Culture of Adipose-derived Stromal Cells